Literature DB >> 15719889

Distribution and determinants of serum creatinine in the general population: the Hordaland Health Study.

B E Vikse1, S E Vollset, G S Tell, H Refsum, B M Iversen.   

Abstract

BACKGROUND: Serum creatinine is a well-recognized risk factor for cardiovascular disease (CVD) and is also a rough measure of glomerular filtration rate. The purpose of the present study was to investigate determinants of serum creatinine in the general population.
METHODS: The participants were recruited as a part of the Hordaland Health Study, and included 6952 men aged 41-49 years, 8218 women aged 41-49 years, 1470 men aged 71-74 years and 1865 women aged 71-74 years. Data on lifestyle factors, medical history and medication were obtained through questionnaires. Body size and blood pressure measurements as well as non-fasting blood samples were obtained during a health examination. Determinants of serum creatinine were identified using multiple linear and logistic regression analyses.
RESULTS: Male and older participants had higher levels of serum creatinine than female and middle-aged participants. For older participants, creatinine was associated with serum triglycerides, CVD, upper-arm circumference and use of antihypertensive drugs as well as inversely associated with cigarette smoking. For middle-aged participants, creatinine was associated with upper-arm circumference, serum lipids and physical exercise, as well as inversely associated with smoking and alcohol intake. The associations with CVD risk factors were much stronger for older participants than for middle-aged participants and most associations were significant after adjustments as well as present within the reference range of serum creatinine.
CONCLUSIONS: In this general population sample, high serum creatinine levels were associated with risk factors for CVD. These associations were stronger in older subjects, whereas in middle-aged subjects lifestyle variables were relatively more important.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15719889     DOI: 10.1080/00365510410003057

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  13 in total

1.  Relation between serum creatinine and body mass index in elite athletes of different sport disciplines.

Authors:  G Banfi; M Del Fabbro; G Lippi
Journal:  Br J Sports Med       Date:  2006-05-24       Impact factor: 13.800

Review 2.  Serum creatinine concentration and creatinine-based estimation of glomerular filtration rate in athletes.

Authors:  Giuseppe Banfi; Massimo Del Fabbro; Giuseppe Lippi
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

3.  Serum creatinine and prostate cancer risk in a prospective study.

Authors:  Stephanie J Weinstein; Katrina Mackrain; Rachael Z Stolzenberg-Solomon; Jacob Selhub; Jarmo Virtamo; Demetrius Albanes
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-09-15       Impact factor: 4.254

4.  Metabolic risk factors associated with serum creatinine in a non-diabetic population.

Authors:  Jens Kronborg; Trond Jenssen; Inger Njølstad; Ingrid Toft; Bjørn O Eriksen
Journal:  Eur J Epidemiol       Date:  2007-07-25       Impact factor: 8.082

5.  3-Hydroxyisobutyrate, A Strong Marker of Insulin Resistance in Type 2 Diabetes and Obesity That Modulates White and Brown Adipocyte Metabolism.

Authors:  Mona S Nilsen; Regine Å Jersin; Arve Ulvik; André Madsen; Adrian McCann; Per-Arne Svensson; Maria K Svensson; Bjørn G Nedrebø; Oddrun A Gudbrandsen; Grethe S Tell; C R Kahn; Per M Ueland; Gunnar Mellgren; Simon N Dankel
Journal:  Diabetes       Date:  2020-06-25       Impact factor: 9.461

6.  Pharmacodynamic evaluation of suppression of in vitro resistance in Acinetobacter baumannii strains using polymyxin B-based combination therapy.

Authors:  Nayara Helisandra Fedrigo; Danielle Rosani Shinohara; Josmar Mazucheli; Sheila Alexandra Belini Nishiyama; Floristher Elaine Carrara-Marroni; Frederico Severino Martins; Peijuan Zhu; Mingming Yu; Sherwin Kenneth B Sy; Maria Cristina Bronharo Tognim
Journal:  Sci Rep       Date:  2021-05-31       Impact factor: 4.379

7.  Cystatin C Predicts Incident Cardiovascular Disease in Twins.

Authors:  Johannes Arpegård; Patrik K E Magnusson; Xu Chen; Peter Ridefelt; Nancy L Pedersen; Ulf De Faire; Per Svensson
Journal:  J Am Heart Assoc       Date:  2016-06-27       Impact factor: 5.501

8.  Interferon-γ-induced inflammatory markers and the risk of cancer: the Hordaland Health Study.

Authors:  Hui Zuo; Grethe S Tell; Stein E Vollset; Per M Ueland; Ottar Nygård; Øivind Midttun; Klaus Meyer; Arve Ulvik; Simone J P M Eussen
Journal:  Cancer       Date:  2014-06-19       Impact factor: 6.860

9.  Plasma Biomarkers of Inflammation, the Kynurenine Pathway, and Risks of All-Cause, Cancer, and Cardiovascular Disease Mortality: The Hordaland Health Study.

Authors:  Hui Zuo; Per M Ueland; Arve Ulvik; Simone J P M Eussen; Stein E Vollset; Ottar Nygård; Øivind Midttun; Despoina Theofylaktopoulou; Klaus Meyer; Grethe S Tell
Journal:  Am J Epidemiol       Date:  2016-01-27       Impact factor: 4.897

10.  Guanidinoacetic Acid and Creatine are Associated with Cardiometabolic Risk Factors in Healthy Men and Women: A Cross-Sectional Study.

Authors:  Sergej M Ostojic; Milan Vranes; Davor Loncar; Natasa Zenic; Damir Sekulic
Journal:  Nutrients       Date:  2018-01-13       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.